tiprankstipranks
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
Holding RPRX?
Track your performance easily

Royalty Pharma (RPRX) Financial Statements

1,215 Followers

Royalty Pharma Financial Overview

Royalty Pharma's market cap is currently ―. The company's EPS TTM is $2.556; its P/E ratio is 10.17; and it has a dividend yield of 3.24%. Royalty Pharma is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $0.98. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 564.69M$ 537.27M$ 567.98M$ 596.07M$ 536.31M
Gross Profit$ 564.69M$ 537.27M$ 567.98M$ 596.07M$ 536.31M
EBIT$ 735.07M$ 243.39M$ 39.96M$ 764.84M$ 122.08M
EBITDA$ 740.42M$ 243.39M$ 39.96M$ 764.84M$ 122.08M
Net Income Common Stockholders$ 543.99M$ 151.02M$ 4.78M$ 494.34M$ 72.11M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 998.55M$ 1.80B$ 872.00M$ 495.31M$ 941.75M
Total Assets$ 18.04B$ 17.66B$ 16.13B$ 16.38B$ 15.86B
Total Debt$ 7.61B$ 7.60B$ 6.14B$ 6.14B$ 6.13B
Net Debt$ 6.61B$ 5.80B$ 5.27B$ 5.64B$ 5.19B
Total Liabilities$ 7.78B$ 7.90B$ 6.27B$ 6.30B$ 6.27B
Stockholders Equity$ 6.87B$ 6.48B$ 6.50B$ 6.53B$ 6.14B
Cash Flow-
Free Cash Flow$ 703.61M$ 658.21M$ 664.64M$ 772.63M$ 573.52M
Operating Cash Flow$ 703.61M$ 658.21M$ 664.64M$ 772.63M$ 573.52M
Investing Cash Flow$ -1.19B$ -893.18M$ -86.65M$ -1.00B$ -450.66M
Financing Cash Flow$ -325.50M$ 1.16B$ -212.00M$ -231.89M$ -1.36B
Currency in USD

Royalty Pharma Earnings and Revenue History

Royalty Pharma Debt to Assets

Royalty Pharma Cash Flow

Royalty Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis